MTOR and ovarian carcinoma: In the present research, we concentrated on miR-582-3p and aligned it with its upstream regulator lncRNA TUG1 and downstream target, the AKT/mTOR signaling pathway, to explore the behavior of this miRNA in the biology of ovarian cancer.